CHINA: Notice from CNDA on the Amendments of Submission Documents for Renewal and Clinical Trial Application – June 2018

• 2020-02-14 04:17:02

In order to optimize the efficiency of approval process, China Drug Administration (CNDA) has proposed amendments for submission documents for the renewal and clinical trial application of medical devices. This notice was issued at the end of May.

More